ASO Author Reflections: How can we Measure an Abscopal Effect Seen with Cryoablation?

Annals of Surgical Oncology -     

2015年重庆市肿瘤登记地区宫颈癌疾病负担分析

目的:了解2015年重庆市宫颈癌发病率、死亡率、伤残调整寿命年。方法:收集整理2015年重庆市11个肿瘤登记点报告的宫颈癌发病死亡病例（ICD-10编码为C53）。统计分析宫颈癌发病率、死亡率、标化发病率、标化死亡率、发病和死亡截缩率、发病或死亡累积危险度、早死所致的寿命损失年、残疾所致寿命损失年、伤残调整寿命年等指标。城市与农村宫颈癌发病率与死亡率的比较采用χ2检验。 结果:2015年重庆市肿瘤登记地区共报告宫颈癌新发病例916例，宫颈癌粗发病率为18.29/105，标化发病率为14.26/105，标化发病率农村（15.60/105）高于城市（12.32/105），差异有统计学意义（P<0.001）。2015年共报告宫颈癌死亡病例283例，粗死亡率为5.65/105，标化死亡率为3.98/105。2015年重庆市宫颈癌截缩发病率为32.60/105，截缩死亡率为8.32/105，发病率与死亡率累积危险度分别为1.41%与0.49%。宫颈癌导致的DALYs、YLDs 和YLLs分别是6.76千人年、5.00千人年与1.76千人年。结论:重庆市宫颈癌发病率与死亡率高于全国平均水平，疾病负担重，疾病负担农村高于城市。     

Novel intronic variant in PALB2 gene and effective prevention of Fanconi anemia in family

Familial Cancer - Despite the acceptance of NextGen sequencing as a diagnostic modality suitable for probands and carriers of Mendelian diseases, its efficiency in identifying causal mutations is...     

An evaluation of empagliflozin and it’s applicability to hypertension as a therapeutic option

ABSTRACT

Introduction

Sodium-glucose cotransporter 2 (SGLT2) inhibitors such as Empagliflozin are novel antihyperglycemic drugs approved for the treatment of type 2 diabetes (T2D). In addition to its glucose-lowering effects, Empagliflozin promotes weight loss, blood pressure reduction, and other beneficial metabolic benefits.     

Comment on “The effect of omalizumab on hematological and inflammatory parameters in patients with chronic spontaneous urticarial”: reply from authors

Abstract

We read Cosansu’s commentary entitled “Effectiveness of the new inflammatory parameters in patients with chronic spontaneous urticarial” to our study with great interest. The author remarked that a limited number of patients had C-reactive protein levels and it was not specified whether there were any other drugs used by the patients and no information was given about the severity of the disease in our study.